Decreased Global EEG Synchronization in Amyloid Positive Mild Cognitive Impairment and Alzheimer’s Disease Patients—Relationship to <i>APOE ε4</i>

Decreased Global EEG Synchronization in Amyloid Positive Mild Cognitive Impairment and Alzheimer’s Disease Patients—Relationship to <i>APOE ε4</i>

The apolipoprotein E (<i>APOE</i>) <i>ε4</i> allele is a risk factor for Alzheimer’s disease (AD) that has been linked to changes in brain structure and function as well as to different biological subtypes of the disease. The present study aimed to investigate the association...

Full description

Bibliographic Details
Main Authors:	Una Smailovic, Charlotte Johansson, Thomas Koenig, Ingemar Kåreholt, Caroline Graff, Vesna Jelic
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Series:	Brain Sciences
Subjects:	quantitative electroencephalography apolipoprotein E Alzheimer’s disease mild cognitive impairment amyloid pathology
Online Access:	https://www.mdpi.com/2076-3425/11/10/1359

Similar Items

Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-𝜷 in mild cognitive impairment but not in Alzheimer’s disease
by: Feng Xing, et al.
Published: (2021-06-01)

Relationship between the Presence of the <i>ApoE ε</i>4 Allele and EEG Complexity along the Alzheimer’s Disease Continuum
by: Víctor Gutiérrez-de Pablo, et al.
Published: (2020-07-01)

Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach
by: Una Smailovic, et al.
Published: (2019-12-01)

Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid
by: Yen Ying Lim, et al.
Published: (2021-01-01)

Changes of Functional and Directed Resting-State Connectivity Are Associated with Neuronal Oscillations, ApoE Genotype and Amyloid Deposition in Mild Cognitive Impairment
by: Lars Michels, et al.
Published: (2017-09-01)

Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab
by: Lawren VandeVrede, et al.
Published: (2020-01-01)

APOEε4 Carriers Exhibit Objective Cognitive Deficits: A Cross-Sectional Study in a Single Center Trial
by: Yanfang Zeng, et al.
Published: (2024-03-01)

APOE ε4-dependent effects on the early amyloid pathology in induced neurons of patients with Alzheimer’s disease
by: Hongwon Kim, et al.
Published: (2022-10-01)

Association of pancreatic polypeptide with mild cognitive impairment varies by APOE ε4 allele
by: Rosebud O. Roberts, et al.
Published: (2015-09-01)

A Case of Cerebral Amyloid Angiopathy-Related Inflammation With the Rare Apolipoprotein ε2/ε2 Genotype
by: Yin-Yan Xu, et al.
Published: (2019-05-01)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
by: Yulan Fan, et al.
Published: (2021-04-01)

EEG-fMRI Signal Coupling Is Modulated in Subjects With Mild Cognitive Impairment and Amyloid Deposition
by: Lars Michels, et al.
Published: (2021-04-01)

Apathy and APOE in mild behavioral impairment, and risk for incident dementia
by: Daniella Vellone, et al.
Published: (2022-01-01)

The Effect of Apolipoprotein E ε4 (APOE ε4) on Visuospatial Working Memory in Healthy Elderly and Amnestic Mild Cognitive Impairment Patients: An Event-Related Potentials Study
by: Li-Hua Gu, et al.
Published: (2017-05-01)

Decreased Electroencephalography Global Field Synchronization in Slow-Frequency Bands Characterizes Synaptic Dysfunction in Amnestic Subtypes of Mild Cognitive Impairment
by: Una Smailovic, et al.
Published: (2022-04-01)

APOE ε4/ε4 homozygotes with early Alzheimer's disease show accelerated hippocampal atrophy and cortical thinning that correlates with cognitive decline
by: Susan Abushakra, et al.
Published: (2020-01-01)

ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
by: Emily B. Button, et al.
Published: (2019-05-01)

ApoE Isoforms Inhibit Amyloid Aggregation of Proinflammatory Protein S100A9
by: Shamasree Ghosh, et al.
Published: (2024-02-01)

The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment
by: Hyung-Ji Kim, et al.
Published: (2022-07-01)

Impact of Transcranial Direct Current Stimulation on Cognitive Function, Brain Functional Segregation, and Integration in Patients with Mild Cognitive Impairment According to Amyloid-Beta Deposition and <i>APOE</i> ε4-Allele: A Pilot Study
by: Dong-Woo Kang, et al.
Published: (2021-06-01)

ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis[S]
by: Yaoyong Wang (王耀勇), et al.
Published: (2011-08-01)

Dysfunctional Incidental Olfaction in Mild Cognitive Impairment (MCI): An Electroencephalography (EEG) Study
by: Cornelia Duregger, et al.
Published: (2011-10-01)

In Silico Analysis of the Antagonist Effect of Enoxaparin on the ApoE4–Amyloid-Beta (A<i>β</i>) Complex at Different pH Conditions
by: Jorge Alberto Aguilar-Pineda, et al.
Published: (2022-03-01)

Quantitative Electroencephalography Analyzed by Statistical Pattern Recognition as a Diagnostic and Prognostic Tool in Mild Cognitive Impairment: Results from a Nordic Multicenter Cohort Study
by: Malene Schjønning Nielsen, et al.
Published: (2018-11-01)

Communicating mild cognitive impairment diagnoses with and without amyloid imaging
by: Joshua D. Grill, et al.
Published: (2017-05-01)

Human Serum Amyloid a Impaired Structural Stability of High-Density Lipoproteins (HDL) and Apolipoprotein (Apo) A-I and Exacerbated Glycation Susceptibility of ApoA-I and HDL
by: Kyung-Hyun Cho
Published: (2022-07-01)

Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease
by: Ana-Caroline Raulin, et al.
Published: (2024-02-01)

SMR/Theta Neurofeedback Training Improves Cognitive Performance and EEG Activity in Elderly With Mild Cognitive Impairment: A Pilot Study
by: Fabienne Marlats, et al.
Published: (2020-06-01)

<i>APOE</i> Allele Frequency in Southern Greece: Exploring the Role of Geographical Gradient in the Greek Population
by: Vasiliki Papastefanopoulou, et al.
Published: (2022-12-01)

Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice
by: Hiroshi Hosoai, et al.
Published: (1999-04-01)

Association of CSF GAP-43 and <i>APOE</i> ε4 with Cognition in Mild Cognitive Impairment and Alzheimer’s Disease
by: Yueli Zhu, et al.
Published: (2022-12-01)

Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer’s disease using EEG technology
by: Bin Jiao, et al.
Published: (2023-02-01)

Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment
by: Nor A. Samat, et al.
Published: (2017-12-01)

Impact of Amyloid Pathology in Mild Cognitive Impairment Subjects: The Longitudinal Cognition and Surface Morphometry Data
by: Hsin-I Chang, et al.
Published: (2022-11-01)

Dietary fat modulation of apoA-II metabolism and prevention of senile amyloidosis in the senescence- accelerated mouse
by: Makiko Umezawa, et al.
Published: (2003-04-01)

Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles
by: Rosie M. Walker, et al.
Published: (2021-01-01)

Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
by: Jessica Camacho, et al.
Published: (2019-03-01)

Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy
by: Yoshinori Endo, et al.
Published: (2019-01-01)

Identification of an APOE ε4–specific blood‐based molecular pathway for Alzheimer's disease risk
by: Qiushan Tao, et al.
Published: (2023-10-01)

Neurophysiological markers in community-dwelling older adults with mild cognitive impairment: an EEG study
by: Osamu Katayama, et al.
Published: (2023-12-01)